(CSX) CSX - Overview
Sector: Industrials | Industry: Railroads | Exchange: NASDAQ (USA) | Market Cap: 87.593m USD | Total Return: 48.4% in 12m
Avg Turnover: 547M
EPS Trend: -90.1%
Qual. Beats: 1
Rev. Trend: -93.9%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
Supp Ema20, Idiosyncratic Leader, Confidence
CSX Corporation is a major North American Class I railroad providing rail-based freight transportation across 26 states east of the Mississippi River, the District of Columbia, and two Canadian provinces. The company operates a network of approximately 20,000 route miles and maintains a fleet of 3,400 locomotives to support its rail and trucking segments.
The business model relies on high-barrier-to-entry infrastructure to transport a diverse range of commodities, including chemicals, agricultural products, minerals, and coal. Unlike long-haul trucking, rail transportation offers significant fuel efficiency advantages, often moving one ton of freight several hundred miles on a single gallon of fuel.
In addition to traditional carload services, CSX manages an intermodal network of 30 terminals that facilitates the movement of consumer goods via containers and trailers. This multimodal approach allows the company to capture freight volume from non-rail served customers through rail-to-truck transfer facilities and drayage services.
Investors may find further insights on valuation and historical performance by exploring ValueRay.
- Export coal demand and global steel production drive bulk volume revenue
- Operating ratio improvements through precision scheduled railroading lower core expenses
- Intermodal shipping volume fluctuates based on consumer spending and retail inventory levels
- Labor union negotiations and federal safety regulations impact long-term operating costs
- Industrial production output in the Eastern United States dictates chemical and automotive freight turnover
| Net Income: 3.05b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.09 > 0.02 and ΔFCF/TA 3.10 > 1.0 |
| NWC/Revenue: -0.78% < 20% (prev -2.81%; Δ 2.03% < -1%) |
| CFO/TA 0.10 > 3% & CFO 4.63b > Net Income 3.05b |
| Net Debt (18.7b) to EBITDA (6.47b): 2.89 < 3 |
| Current Ratio: 0.97 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.86b) vs 12m ago -1.59% < -2% |
| Gross Margin: 37.54% > 18% (prev 0.35%; Δ 3.72k% > 0.5%) |
| Asset Turnover: 32.37% > 50% (prev 33.06%; Δ -0.69% > 0%) |
| Interest Coverage Ratio: 5.66 > 6 (EBITDA TTM 6.47b / Interest Expense TTM 848.0m) |
| A: -0.00 (Total Current Assets 3.11b - Total Current Liabilities 3.22b) / Total Assets 44.2b |
| B: 0.25 (Retained Earnings 10.9b / Total Assets 44.2b) |
| C: 0.11 (EBIT TTM 4.80b / Avg Total Assets 43.7b) |
| D: 0.41 (Book Value of Equity 12.5b / Total Liabilities 30.7b) |
| Altman-Z'' = 1.95 = BBB |
| DSRI: 1.04 (Receivables 1.39b/1.35b, Revenue 14.2b/14.3b) |
| GMI: 0.94 (GM 37.54% / 35.29%) |
| AQI: 1.10 (AQ_t 0.10 / AQ_t-1 0.09) |
| SGI: 0.99 (Revenue 14.2b / 14.3b) |
| TATA: -0.04 (NI 3.05b - CFO 4.63b) / TA 44.2b) |
| Beneish M = -3.03 (Cap -4..+1) = AA |
As of May 29, 2026, the stock is trading at USD 45.81 with a total of 15,803,358 shares traded.
Over the past week, the price has changed by -0.28%,
over one month by +1.28%,
over three months by +7.31% and
over the past year by +48.40%.
CSX has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy CSX.
- StrongBuy: 11
- Buy: 5
- Hold: 11
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 45.9 | 0.2% |
P/E Trailing = 28.9202
P/E Forward = 24.6914
P/S = 6.1899
P/B = 6.38
P/EG = 2.126
Revenue TTM = 14.2b USD
EBIT TTM = 4.80b USD
EBITDA TTM = 6.47b USD
Long Term Debt = 18.2b USD (from longTermDebt, last quarter)
Short Term Debt = 710.0m USD (from shortTermDebt, last quarter)
Debt = 19.8b USD (from shortLongTermDebtTotal, last quarter) + Leases 469.0m
Net Debt = 18.7b USD (calculated: Debt 19.8b - CCE 1.11b)
Enterprise Value = 106b USD (87.6b + Debt 19.8b - CCE 1.11b)
Interest Coverage Ratio = 5.66 (Ebit TTM 4.80b / Interest Expense TTM 848.0m)
EV/FCF = 25.74x (Enterprise Value 106b / FCF TTM 4.13b)
FCF Yield = 3.88% (FCF TTM 4.13b / Enterprise Value 106b)
FCF Margin = 29.18% (FCF TTM 4.13b / Revenue TTM 14.2b)
Net Margin = 21.55% (Net Income TTM 3.05b / Revenue TTM 14.2b)
Gross Margin = 37.54% ((Revenue TTM 14.2b - Cost of Revenue TTM 8.84b) / Revenue TTM)
Gross Margin QoQ = 47.90% (prev 31.64%)
Tobins Q-Ratio = 2.40 (Enterprise Value 106b / Total Assets 44.2b)
Interest Expense / Debt = 4.28% (Interest Expense 848.0m / Debt 19.8b)
Taxrate = 24.08% (256.0m / 1.06b)
NOPAT = 3.64b (EBIT 4.80b * (1 - 24.08%))
Current Ratio = 0.97 (Total Current Assets 3.11b / Total Current Liabilities 3.22b)
Debt / Equity = 1.46 (Debt 19.8b / totalStockholderEquity, last quarter 13.6b)
Debt / EBITDA = 2.89 (Net Debt 18.7b / EBITDA 6.47b)
Debt / FCF = 4.53 (Net Debt 18.7b / FCF TTM 4.13b)
Total Stockholder Equity = 13.0b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.98% (Net Income 3.05b / Total Assets 44.2b)
RoE = 23.52% (Net Income TTM 3.05b / Total Stockholder Equity 13.0b)
RoCE = 15.42% (EBIT 4.80b / Capital Employed (Equity 13.0b + L.T.Debt 18.2b))
RoIC = 8.73% (NOPAT 3.64b / Invested Capital 41.7b)
WACC = 7.60% (E(87.6b)/V(107b) * Re(8.58%) + D(19.8b)/V(107b) * Rd(4.28%) * (1-Tc(0.24)))
Discount Rate = 8.58% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -100.00 | Cagr: -2.45%
[DCF] Terminal Value 77.97% ; FCFF base≈3.56b ; Y1≈4.08b ; Y5≈6.00b
[DCF] Fair Price = 38.51 (EV 90.3b - Net Debt 18.7b = Equity 71.6b / Shares 1.86b; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: -90.08 | EPS CAGR: -6.15% | SUE: 2.04 | # QB: 1
Revenue Correlation: -93.91 | Revenue CAGR: -2.15% | SUE: -0.17 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.49 | Chg30d=+1.78% | Revisions=+43% | Analysts=20
EPS next Quarter (2026-09-30): EPS=0.51 | Chg30d=+2.05% | Revisions=+70% | Analysts=20
EPS current Year (2026-12-31): EPS=1.91 | Chg30d=+3.25% | Revisions=+50% | GrowthEPS=+18.4% | GrowthRev=+4.9%
EPS next Year (2027-12-31): EPS=2.16 | Chg30d=+3.36% | Revisions=+83% | GrowthEPS=+13.5% | GrowthRev=+4.7%
[Analyst] Revisions Ratio: +83%